Results 31 to 40 of about 5,855 (210)

Update on Anxiolytics and Hypnotics [PDF]

open access: yes, 1992
Goal The goal of this article is to educate pharmacists on the new er anxiolytic and hypnotic agents. Objectives After reading this article, the pharmacist shouid be able to: • Discuss the advantages of the new hypnotics and anxiolytics over previous ...
Gutierrez, Mary   +2 more
core   +1 more source

Using anxiolytics in epilepsy: neurobiological, neuropharmacological and clinical aspects. [PDF]

open access: yes, 2016
Anxiety disorders represent a common psychiatric comorbidity in patients with epilepsy, affecting prognosis and quality of life. However, they are still underdiagnosed and undertreated.
Mula, M, Marco Mula
core   +1 more source

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2022
Considering the allosteric regulation of mGlu receptors for potential therapeutic applications, we developed a group of 1,2,4-oxadiazole derivatives that displayed mGlu4 receptor positive allosteric modulatory activity (EC50 = 282–656 nM).
Anna Stankiewicz   +12 more
doaj   +1 more source

An update on the pharmacological treatment of anxiety and related disorders

open access: yesSouth African Family Practice, 2016
The anxiety disorders, obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are common and debilitating, often coexist with medical and psychiatric conditions, and usually require long-term treatment.
K. Outhoff
doaj   +1 more source

Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia [PDF]

open access: yes, 2022
OBJECTIVE: To study patterns of antidepressant, anxiolytic, and hypnotic drug utilization in Denmark, Norway, and Sweden during the first year of the COVID-19 pandemic.
Wesselhoeft, Rikke; id_orcid   +26 more
core   +1 more source

Anxiolytics

open access: yes, 2012
Childhood anxiety disorders are traditionally treated with selective serotonin reuptake inhibitors (SSRIs). Other anxiolytics, including benzodiazepines, antihistamines, and buspirone are also used to treat anxiety and sleep disorders in youth ...
Coffey, Barbara J   +3 more
core   +1 more source

Anxiolytics: past, present, and future agents

open access: yes, 2003
Although anxiety disorders were classified as neurotic disorders and not systematically studied before DSM-III, researchers and clinicians have been searching for effective, safe agents to treat anxiety symptoms and disorders for over a century.
Nemeroff, Charles B
core   +2 more sources

Trends in the Use of Anxiolytics in Castile and Leon, Spain, between 2015–2020: Evaluating the Impact of COVID-19

open access: yes, 2021
Anxiolytics (N05B) are one of the most widely used pharmacological groups. This study aimed to analyze the progression of the consumption of anxiolytics (ATC classification: N05B) dispensed in pharmacies in Castile and Leon, Spain, from 2015 to 2020 ...
María Luisa Martín-Calvo   +2 more
core   +1 more source

Boundary‐Dependent Sleep–Wake Dysregulation in Idiopathic Hypersomnia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Idiopathic hypersomnia (IH) presents with excessive daytime sleepiness (EDS) despite apparently preserved nocturnal sleep, challenging traditional models of hypersomnolence based on sleep loss or fragmentation. We aimed to test the hypothesis that EDS in IH reflects excessive stabilization of the sleep state, consistent with ...
Samantha Mombelli   +13 more
wiley   +1 more source

PRESCRIBING CHANGES IN ANXIOLYTICS AND ANTIDEPRESSANTS IN SLOVENIA [PDF]

open access: yes, 2011
Background: The ratio of anxiolytics to antidepressants is an indicator of the quality of treatment of depression and anxiety in primary care. The objective of the study was to investigate the prescription of anxiolytics and antidepressants among ...
Vidmar, Gaj, Šubelj, Maja, Švab, Vesna
core   +1 more source

Home - About - Disclaimer - Privacy